Health CanadaGeneral Alert
Taro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, r...
Published: August 9, 2022Recall ID: 64457Category: generalCountry: Canada
Reason for Recall / Hazard
Product quality
Product Description & Identification
Check your product or contact your pharmacist to determine if it is affected. If you have a recalled product, do not use it and return it to your pharmacy for a replacement product and proper disposal.If you have used the recalled product and have health concerns, contact your healthcare provider. Go to the hospital immediately if you develop difficulty breathing, chest pain or confusion.Contact Taro Pharmaceuticals Inc. by calling toll free at 1-800-268-1975 if you have questions about this recall.Report any health product adverse events or complaints to Health Canada.
Affected Products
Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100)
Additional Source Details
| Field | Value |
|---|---|
| N I D | 64457 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/taro-zoledronic-acid-injection-drug-used-osteoporosis-and-page-s-disease-recalled |
| Issue | Product quality |
| Title | Taro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, recalled because it may contain particulate matter |
| Product | Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100) |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2022-08-09 |
| Organization | Communications and Public Affairs Branch |
| What you should do | Check your product or contact your pharmacist to determine if it is affected. If you have a recalled product, do not use it and return it to your pharmacy for a replacement product and proper disposal.If you have used the recalled product and have health concerns, contact your healthcare provider. Go to the hospital immediately if you develop difficulty breathing, chest pain or confusion.Contact Taro Pharmaceuticals Inc. by calling toll free at 1-800-268-1975 if you have questions about this recall.Report any health product adverse events or complaints to Health Canada. |